Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 |
filingDate |
2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef0e584e92d58455100a06c069f66a28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98bbe6c7d29b0b06966ef7c7531c05c9 |
publicationDate |
2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-104684904-A |
titleOfInvention |
Attenuation of central corneal thickening by use of a hydrophilic ester prodrug of β-chlorocyclopentane |
abstract |
The present invention provides compositions and methods for treating glaucoma. Specifically, the present invention provides hydrophilic ester prodrugs of formula (I) and formula (III) and said compounds for reducing central corneal thickening, wherein L1-L3, R1 and R2 are as claimed in claim 1 and n and R2D are as defined in claim 37. |
priorityDate |
2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |